BSE Live
Feb 27, 15:40Prev. Close
176.55
Open Price
176.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 27, 15:57Prev. Close
176.81
Open Price
175.86
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
173.93 (338)
| Key Financial Ratios of Marksans Pharma (in Rs. Cr.) | Mar 05 | |
| Per Share Ratios | ||
| Basic EPS (Rs.) | 5.72 | |
| Diluted EPS (Rs.) | 5.72 | |
| Cash EPS (Rs.) | 7.82 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 24.71 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 24.71 | |
| Revenue from Operations/Share (Rs.) | 68.43 | |
| PBDIT/Share (Rs.) | 12.22 | |
| PBIT/Share (Rs.) | 10.29 | |
| PBT/Share (Rs.) | 6.97 | |
| Net Profit/Share (Rs.) | 5.72 | |
| NP After MI And SOA / Share (Rs.) | 5.72 | |
| Profitability Ratios | ||
| PBDIT Margin (%) | 17.85 | |
| PBIT Margin (%) | 15.03 | |
| PBT Margin (%) | 10.19 | |
| Net Profit Margin (%) | 8.35 | |
| NP After MI And SOA Margin (%) | 8.35 | |
| Return on Networth/Equity (%) | 23.15 | |
| Return on Capital Employed (%) | 12.42 | |
| Return on Assets (%) | 8.73 | |
| Total Debt/Equity (X) | 1.01 | |
| Asset Turnover Ratio (%) | 104.53 | |
| Liquidity Ratios | ||
| Current Ratio (X) | 1.88 | |
| Quick Ratio (X) | 1.13 | |
| Inventory Turnover Ratio (X) | 4.69 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | |
| Coverage Ratios | ||
| Interest Coverage Ratios (%) | 3.11 | |
| Interest Coverage Ratios (Post Tax) (%) | 3.11 | |
| Valuation Ratios | ||
| Enterprise Value (Cr.) | 1,238.44 | |
| EV/Net Operating Revenue (X) | 5.04 | |
| EV/EBITDA (X) | 28.20 | |
| MarketCap/Net Operating Revenue (X) | 4.66 | |
| Retention Ratios (%) | 0.00 | |
| Price/BV (X) | 12.89 | |
| Price/Net Operating Revenue | 4.66 | |
| Earnings Yield | 0.02 |
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Buy Marksans Pharma; target of Rs 225: Choice Institutional Equities
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y